US Pharmaceutical Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. US Pharmaceutical Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. US Pharmaceutical Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. US Pharmaceutical Market Country Analysis

6.2 US Pharmaceutical Market Revenue 2020-2030 (US$ Billion)

6.3 US Pharmaceutical Market Forecast Analysis

7. US Pharmaceutical Market Analysis – by Product

7.1 Vaccines

7.1.1 Overview
7.1.2 Vaccines: US Pharmaceutical Market – Revenue and Forecast, 2020-2030 (US$ Billion)

7.2 Biologics & Biosimilars

7.2.1 Overview
7.2.2 Biologics & Biosimilars: US Pharmaceutical Market – Revenue and Forecast, 2020-2030 (US$ Billion)

7.3 Small Molecules

7.3.1 Overview
7.3.2 Small Molecules : US Pharmaceutical Market – Revenue and Forecast, 2020-2030 (US$ Billion)

8. US Pharmaceutical Market – United States Analysis

8.1 United States

8.1.1 United States: US Pharmaceutical Market – Revenue and Forecast to 2030 (US$ Billion)

8.1.1.1 United States: US Pharmaceutical Market Breakdown, by Product

9. Competitive Landscape

9.1 Heat Map Analysis

9.2 Company Positioning and Concentration

10. Industry Landscape

10.1 Overview

10.2 Market Initiative

10.3 Partnerships and Collaborations

10.4 Other Developments

11. Company Profiles

11.1 Moderna Inc

11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments

11.2 AbbVie Inc

11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments

11.3 Gilead Sciences Inc

11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments

11.4 Regeneron Pharmaceuticals Inc

11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments

11.5 Merck & Co Inc

11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments

11.6 Abbott Laboratories

11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments

11.7 Bristol-Myers Squibb Co

11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments

11.8 Vertex Pharmaceuticals Inc

11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments

11.9 Pfizer Inc

11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments

11.10 Eli Lilly and Co

11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments

11.11 Bayer AG

11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Products and Services
11.11.4 Financial Overview
11.11.5 SWOT Analysis
11.11.6 Key Developments

11.12 Johnson & Johnson

11.12.1 Key Facts
11.12.2 Business Description
11.12.3 Products and Services
11.12.4 Financial Overview
11.12.5 SWOT Analysis
11.12.6 Key Developments

11.13 Amgen Inc

11.13.1 Key Facts
11.13.2 Business Description
11.13.3 Products and Services
11.13.4 Financial Overview
11.13.5 SWOT Analysis
11.13.6 Key Developments

11.14 Takeda Pharmaceutical Co Ltd

11.14.1 Key Facts
11.14.2 Business Description
11.14.3 Products and Services
11.14.4 Financial Overview
11.14.5 SWOT Analysis
11.14.6 Key Developments

11.15 Zoetis Inc

11.15.1 Key Facts
11.15.2 Business Description
11.15.3 Products and Services
11.15.4 Financial Overview
11.15.5 SWOT Analysis
11.15.6 Key Developments

12. Appendix

12.1 About Business Market Insights

12.2 List of Abbreviations

US Pharmaceutical Market

Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Vaccines, Biologics & Biosimilars, and Small Molecules)